SCIENCE AT THE SPEED OF BUSINESS

Our fundamental premise is that innovative methods, analytical rigor, and scientific acumen can be provided in a commercial entity that operates “at the speed of business.” Monument Analytics delivers.

Unparalleled Knowledge Base

One of the most remarkable features of Monument Analytics is its access to consultants with an unparalleled knowledge base. Through its independent consulting services, Monument Analytics leverages this acumen to assist clients developing products and services for the benefit of society.

Top Notch Evidence

By capitalizing on this unparalleled depth and breadth of human capital, Monument Analytics is able to generate the highest quality evidence regarding the safety, effectiveness, and real-world value of the full range of medical processes and technologies; and to use this knowledge to help our clients navigate evermore complex and challenging regulatory and payment environments.

Internationally Renowned Experts

Our Principals and Consultants are internationally renowned for their expertise in areas ranging from epidemiology and biostatistics to clinical fields such as cardiovascular medicine, oncology, and immunology.

G. Caleb Alexander
G. Caleb AlexanderMD, MS
CO-FOUNDER & PRINCIPAL
Jonothan C. Tierce
Jonothan C. TierceCPhil
CO-FOUNDER & PRINCIPAL
William V. Padula
William V. PadulaPhD
PRINCIPAL
Natalie Reid
Natalie ReidPhD, MPH, MBA
DIRECTOR
MEET THE CONSULTING TEAM

Services

Our services are broadly organized into four core capabilities

  • Comparative effectiveness analyses
  • Pharmacovigilance and safety assessments
  • Investigations of drug utilization
  • Risk-benefit appraisals
  • Bayesian, meta-analytic and systematic reviews
  • Patient and clinician preferences
  • Global marketplace and pharmaceutical policy
  • Design and conduct of sophisticated comparative effectiveness, pharmacovigilance, and drug utilization studies
  • Advanced techniques for causal inference, management of missing data, and other statistical analysis
  • Cost-benefit analysis and cost-effectiveness analysis
  • Natural history of disease and resource utilization
  • Systematic economic and quality-of-life reviews
  • Core value dossiers

MA in the News

Sept 30, 2020
Bill Padula, Mark Sculpher
Dr. William Padula, Monument Analytics Prinicpal and Dr. Mark Sculpher, Monument Analytics Advisory Board Member, authored a piece in the Annals of Internal Medicine titlied: “Ideas About Resourcing Health Care in the United States: Can Economic Evaluation Achieve Meaningful Use?

Sept 29, 2020
Ben Cohen
Dr. Ben Cohen, Monument Analytics Manger first authored a piece in Health Economics titled: “Improved survival for individuals with common chronic conditions in the Medicare population.”

Sept 29, 2020
Bill Padula, Natalie Reid
Dr. William Padula, Monument Analytics Principal and Dr. Natalie Reid, Monument Analytics’ Director authored a piece in the Journal of Wound and Ostomy and Continence Nursing titled: “Wound, Ostomy, and Continence Nurses Could Be an Answer to the Economic Impact of Coronavirus.”

Sept 29, 2020
Caleb Alexander
Dr. Caleb Alexander, Monument Analytics’ Principle, co-authored a paper in the Annals of Internal Medicine titled: “Key Evidence Supporting Prescription Opioids Approved by the U.S. Food and Drug Administration, 1997 to 2018.”

August 4, 2020
Bill Padula, Shreena Malaviya, Ellen Hu, Jon Tierce
The Monument Analytics team authored a piece in Journal of Patient Safety and Risk Management titled: “The cost-effectiveness of sub-epidermal moisture scanning to assess pressure injury risk in U.S. health systems.”

July 22, 2020
Caleb Alexander
PBS News Hour cited Monument Analytics Principal Dr. Caleb Alexander about how the pandemic is complicating America’s addiction crisis.

July 6, 2020
Caleb Alexander
Kaiser Health News cited Dr. Caleb Alexander, Monument Analytics’ Principle,  as an expert in “Coronavirus Crisis Disrupts Treatment For Another Epidemic: Addiction.”

SEE ALL NEWS